pharmacotherapy & adrenergic drugs Flashcards
Cholinesterase inhibitors (CI) mechanism of action
- prevent breakdown of ACh by acetylcholinesterase
- increase amt of ACh in the neurologic junction
- more ACh is present to activate receptors,
- INDIRECT CHOLINERGIC AGONISTS
what are the two types of cholinesterase inhibitors
- reversible
- irreversible
what are the reverse cholinesterase inhibitors drug
Neostigmine
Physotigmine
Pyridostigmine
muscular effects of reversible cholinesterase inhibitors
therapeutic dose- increase force of muscle contraction
toxic dose- decrease force muscle contraction
CNS effects of reversible cholinesterase inhibitors
therapeutic doses - mild stimulation
toxic doses- depress CNS function and respiratory drive at toxic doses
(must cross BBB)
indication of Neostigmine
- M. gravy,
- reversal of neuromuscular blockage
- treats MG crisis via IV
counseling points for neostagmine
paradoxical anti-cholinesterase weakness can occur
indication of Physostigmine
reversal of anti-cholinergic toxicity (muscarinic antagonist toxicity)
Physostigmine counseling points
rapid IV administration can cause respiratory depression
- seizures and bradycardia
- give SLOW IV push or infusion
Pyridostigmine indication
MG
Pyridostigmine counseling points
- do not crush ER formulation
- time dose of IR formulation to provide maximal function
- avoid holding or delaying doses
Adverse effects of Reversible Cholinesterase Inhibitors (Neostigmine
Physotigmine
Pyridostigmine)
- Bradycardia
- Hypotension
- increased salivation, lacrimation, sweating
- urinary urgency
- neuromuscular blockade
Echothiophate (irreversible cholinesterase inhibitors) eye drops for glaucoma effect
increase drainage and decrease intraocular pressure
antidote/treatment for irreversible cholinestrerase
pralidoxime
tretaments of irreversible CIs
- Atropine
- Pralidoxime (antidote/treatment for pepticide poisoning)
- Benzodiazepines - seizures
key points about pralidoxime
- forces irreversible CI to dissociate from cholinesterase
- most effective at the neuromuscular junction, cannot cross BBB,
- MUST be given soon after exposure or will not be effective, given IV or IM via SLOW infusion
muscarinic agonists drugs
Bethanechol
Pilocarpine
what does muscarinic agonists bind to
bind to and activate muscarinic receptors
primary neurotransmitter of the parasympathetic NS
acetylcholine
adrenergic receptors of the sympathehtic nervous system
- Dopamine, norepinephrine, epinephrine
- Beta and alpha
cholinergic receptors of the parasympathetic nervous system
Muscarinic and nicotinic
location of nicotinic N receptor
All ganglia of the autonomic nervous system (ANS)
location of nicotinic M receptor
Neuromuscular junctions (NMJ)
effects of nicotinic N receptors activation
Promotes ganglionic transmission
effects of nicotinic M receptors activation
Skeletal muscle contraction
clinical effects of muscarinic agonists
stimulate PNS (aka parasympathomimetic agents)
mechanism of action Bethanechol
- reversible binding to muscarinic receptors
- causes ACTIVATION
indications of bethanechol
urinary retention
adverse effects of bethanecol
- Bradycardia
- hypotension
- increased salivation,
- increased gastric acid production
- abdominal cramps and diarrhea
- contraction of the bladder and relaxation of sphincter
- exacerbation of asthma
pilocarpine mechanism of action
muscarinic agonist
indications of pilocarpine
- glaucoma
- dry mouth due to
- Sjogren’s Syndrome
adverse effect of pilocarpine
topical - minimal oral - same as bethanecol - Bradycardia - hypotension - increased salivation, - increased gastric acid production - abdominal cramps and diarrhea - contraction of the bladder and relaxation of sphincter - exacerbation of asthma
What are the treatments for muscarinic agonist toxicity?
atropine
supportive care
Antimuscarinic drugs
blocks the actions of
acetylcholine
and influence the activity of cholinergic receptors
other names for muscarinic antagonists
anti-muscarinic
muscarinic blockers
anticholinergic
anticholinergic drugs fro over-active bladder
- Oxybutynin
- DariFENACIN
- SoliFENACIN
- FesoTERODINE
- TolTERODINE
M3 selectivity except fesoterodine and tolterodine
MUSCARINIC ANTAGONISTS drugs
Atropine Oxybutynin Darifenacin Solifenacin Fesoterodine Tolterodine Scopolamine Ipatropium Glycopyrrolate
muscarnic antagonists binds to
bind to muscarinic receptors, competitively block ACh
adverse effect of atropine
(opposite of muscarinic activation)
- Tachycardia
- Decreased salivation, lacrimation, sweating
- Decreased tone and motility
- Decreased tone, sphincter constriction
- Mydriasis (dry eyes)
lower doses of atropine are needed to affect
exocrine glands (lacrimal glands, salivary glands
higher doses of atropine are needed to affect
lungs and stomach
indications of atropine
- preanesthetic medication
- disorders of the eye
- Bradycardia
- GI hypertonicity
- Muscarinic agonist poisoning
indication of Scopolamine
anti-muscarinic/muscarinic blockers/anticholinergic drug.
- motion sickness
- vomiting
- decreased respiratory
- secretions
indication of Ipratropium (antimuscarinic)
- asthma
- COPD
- Rhinitis
counseling point of oxybutynin
- Take with or without food
- Do not crush ER tablets
- Apply patch or gel to clean and dry skin
- Rotate sites of topical administration
Darifenacin, Tolterodine counseline points
Do not crush ER tablets
Solifenacin, Fesoterodine counseling points
Can increase QTc at high doses - avoid with other OTc increased drugs
For anti-cholinergic agent to work in OAB,it must ….
it must inhibit M3 receptors
M3 receptors are specific only to bladder true or false
false.
M3 receptors not specific only to bladder
muscariinic subtype M3 response to activation
- Salivation
- Contraction (↑ pressure)
- Increased tone & motility
- Contraction (miosis)
- Contraction (accommodation)
Tearing
muscariinic subtype M3 impact of blockade
- Dry mouth
- Relaxation (decreased pressure)
- Decreased tone & motility
- Relaxation (mydriasis)
- Relaxation (blurred vision)
- Dry eyes
Adrenergic Receptors
alpha 1, - vasculature and smooth muscle
alpha 2 - cns
beta 1 - heart
dopamine - kidney
what are the two types of adrenergic agonist
catecholamines - do not cross BBB
noncatecholamines- able to cross BBB
drugs of catecholamines
- Epinephrine
- Norepinephrine = SEPTIC SHOCK
- Isoproterenol
- Dobutamine
- Dopamine
drugs of non-catecholamines
- Ephedrine
- Phenylephrine
- Albuterol
Alpha 1 receptor response of activation
location:
blood vessels
eyes
- vasoconstriction
- mydriasis (pupil dilation)
adverse effects of Alpha 1 activation
- hypertension
- bradycardia
- necrosis (extravasation from IV line)
Beta 1 receptor response of activation
location: heart
- increased HR (chronotopy)
- increased force of contraction (inotropy)
adverse effects of beta 1 activation
Tachycardia
Dysrhythmias
Angina
Beta 2 receptor response activation
location:
lungs
blood vessels
uterus
- lungs - bronchodilation
- blood vessels -vasodilation
- uterus - relax smooth muscle
adverse effect of beta 2 receptor activation
hyperglycemia
tremor